 |
|
 |
| |
 |
|
Class Information
Number: 514/177
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein a nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen atom through a double bond (C=O).
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6020327 |
Control of hair growth |
Feb. 1, 2000 |
| 6020356 |
Pharmaceutical composition for the treatment of autoimmune diseases |
Feb. 1, 2000 |
| 6013642 |
Use of estrone derivatives as steroid sulphatase inhibitors |
Jan. 11, 2000 |
| 5994333 |
Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
Nov. 30, 1999 |
| 5985861 |
Progesterone for treating or reducing ischemia |
Nov. 16, 1999 |
| 5981517 |
Androstene derivatives |
Nov. 9, 1999 |
| 5980945 |
Sustained release drug formulations |
Nov. 9, 1999 |
| 5980940 |
Pharmaceutical combination preparation for hormonal contraception |
Nov. 9, 1999 |
| 5972922 |
Steroids which inhibit angiogenesis |
Oct. 26, 1999 |
| 5972921 |
Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men |
Oct. 26, 1999 |
| 5968919 |
Hormone replacement therapy drug formulations for topical application to the skin |
Oct. 19, 1999 |
| 5968918 |
Method for the prevention of coronary artery spasm |
Oct. 19, 1999 |
| 5965550 |
Process for the preparation of 4-amino-.DELTA..sup.4 -3-ketosteroids via 4-nitro-.DELTA..sup.4 -3-ketosteroids |
Oct. 12, 1999 |
| 5965549 |
Ciprofloxacin-hydrocortisone suspension |
Oct. 12, 1999 |
| 5962442 |
Irreversible inhibition of human 5.alpha.-reductase |
Oct. 5, 1999 |
| 5962444 |
17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
Oct. 5, 1999 |
| 5962443 |
19-nur-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
Oct. 5, 1999 |
| 5958912 |
Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-.beta. |
Sep. 28, 1999 |
| 5955454 |
Nasal pharmaceutical composition containing a progestogen |
Sep. 21, 1999 |
| 5935948 |
Method of treating and preventing gallstones |
Aug. 10, 1999 |
| 5919465 |
Methods for augmenting immunological responses through the administration of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) |
Jul. 6, 1999 |
| 5914324 |
6-Hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same |
Jun. 22, 1999 |
| 5906987 |
Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors |
May. 25, 1999 |
| 5895783 |
Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
Apr. 20, 1999 |
| 5888996 |
Inhibition of NMDA receptor activity and modulation of glutamate-mediated synaptic activity |
Mar. 30, 1999 |
| 5885978 |
External therapeutic composition for dermatitis |
Mar. 23, 1999 |
| 5879711 |
Stable antiandrogenic gel composition |
Mar. 9, 1999 |
| 5880116 |
Use of celastrol to treat alzheimer's disease |
Mar. 9, 1999 |
| 5869090 |
Transdermal delivery of dehydroepiandrosterone |
Feb. 9, 1999 |
| 5869475 |
Certain 3-ketosteroids used to inhibit steroid 5.alpha.-reductase |
Feb. 9, 1999 |
| 5869081 |
Progesterone vaginal ring for treatment of infertility |
Feb. 9, 1999 |
| 5866558 |
6-alkynyl steroids |
Feb. 2, 1999 |
| 5861389 |
Methods of treating androgen deficiency in men using selective aromatase inhibitors |
Jan. 19, 1999 |
| 5861387 |
Controlled release systems and low dose androgens |
Jan. 19, 1999 |
| 5855920 |
Total hormone replacement therapy |
Jan. 5, 1999 |
| 5854230 |
Antiandrogenic agents and related pharmaceutical compositions and methods of use |
Dec. 29, 1998 |
| 5847009 |
Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions |
Dec. 8, 1998 |
| 5846960 |
Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds |
Dec. 8, 1998 |
| 5846962 |
Anti-obesity agents |
Dec. 8, 1998 |
| 5843931 |
6,7-modified 11.beta.-aryl-4-oestrenes |
Dec. 1, 1998 |
| 5837698 |
Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs |
Nov. 17, 1998 |
| 5834451 |
Remedy for myotonic dystrophy |
Nov. 10, 1998 |
| 5830432 |
Phospholipid drug derivatives |
Nov. 3, 1998 |
| 5824670 |
17-deoxycorticosteroid-21-[O]carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
Oct. 20, 1998 |
| 5817649 |
Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia |
Oct. 6, 1998 |
| 5814340 |
Controlled release systems and low dose androgens |
Sep. 29, 1998 |
| 5811417 |
Process for producing a sterile prednisolone gel |
Sep. 22, 1998 |
| 5811416 |
Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate |
Sep. 22, 1998 |
| 5811388 |
Delivery of drugs to the lower GI tract |
Sep. 22, 1998 |
| 5804576 |
Derivatives of 5-androsten-17-ones and 5-androstan-17-ones |
Sep. 8, 1998 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
